Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study.
Ontology highlight
SUBMITTER: Caocci G
PROVIDER: S-EPMC7280258 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA